One University Plaza, Suite 307 Hackensack, NJ, 07601 United StatesUS-Head Quartered, End-to-End Oncology Pharmacology Solutions CRO Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platforms and analytics, and scientific excellence, Champions enables the advancement of preclinical oncology drug discovery and development programs and clinical trials worldwide. Champions Oncology offers: PDX models - Solid and Liquid Tumor (<1,200 - WES and RNASeq, patient treatment history and in vivo drug test data available) Syngeneic models (MC38, CT26, 4T1, EMT6, LLC, B16F10, RENCA) Humanized models (PBMC, CD34, NK) Human Cell Line Xenografts Hematological In vivo and Ex Vivo Modeling (AML, ALL, CLL, MCL, DLBCL, MM, CMML, MDS) 3D Tumor Model Studies, 3D Organoid Studies Ex Vivo Co-Culture Studies Clinical Specialty Testing (flow cytometry, western blot, IHC, qPCR, ELISA, Luminex, ImmunoAssays) Clinical Flow Cytometry Services

1330 Piccard Drive Suite 025 Rockville, MD, 20850 United StatesUS-Head Quartered, End-to-End Oncology Pharmacology Solutions CRO Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platforms and analytics, and scientific excellence, Champions enables the advancement of preclinical oncology drug discovery and development programs and clinical trials worldwide. Champions Oncology offers: PDX models - Solid and Liquid Tumor (<1,200 - WES and RNASeq, patient treatment history and in vivo drug test data available) Syngeneic models (MC38, CT26, 4T1, EMT6, LLC, B16F10, RENCA) Humanized models (PBMC, CD34, NK) Human Cell Line Xenografts Hematological In vivo and Ex Vivo Modeling (AML, ALL, CLL, MCL, DLBCL, MM, CMML, MDS) 3D Tumor Model Studies, 3D Organoid Studies Ex Vivo Co-Culture Studies Clinical Specialty Testing (flow cytometry, western blot, IHC, qPCR, ELISA, Luminex, ImmunoAssays) Clinical Flow Cytometry Services

1405 Research Blvd., Suite 125 Rockville, MD, 20850 United StatesUS-Head Quartered, End-to-End Oncology Pharmacology Solutions CRO Champions Oncology is a global preclinical and clinical research services provider that offers end-to-end solutions to biopharma organizations. With the largest and most annotated bank of clinically relevant patient-derived xenograft (PDX) and primary hematological malignancy models, Champions delivers innovative highest-quality data through proprietary in vivo and ex vivo platforms. Through its large portfolio of cutting-edge bioanalytical platforms, groundbreaking data platforms and analytics, and scientific excellence, Champions enables the advancement of preclinical oncology drug discovery and development programs and clinical trials worldwide. Champions Oncology offers: PDX models - Solid and Liquid Tumor (<1,200 - WES and RNASeq, patient treatment history and in vivo drug test data available) Syngeneic models (MC38, CT26, 4T1, EMT6, LLC, B16F10, RENCA) Humanized models (PBMC, CD34, NK) Human Cell Line Xenografts Hematological In vivo and Ex Vivo Modeling (AML, ALL, CLL, MCL, DLBCL, MM, CMML, MDS) 3D Tumor Model Studies, 3D Organoid Studies Ex Vivo Co-Culture Studies Clinical Specialty Testing (flow cytometry, western blot, IHC, qPCR, ELISA, Luminex, ImmunoAssays) Clinical Flow Cytometry Services